オフィスベースラボの市場規模・シェア・成長分析 (セットアップモデル別、サービスの種類別、専門家別、地域別)：産業予測 (2025～2032年)

世界のオフィスベースラボの市場規模は、2023年に306億米ドルと評価され、予測期間 (2025-2032年) のCAGRは12.5%で、2024年の344億3,000万米ドルから2032年には883億3,000万米ドルに成長する見通しです。

世界のオフィスベースラボ (OBL)、またはオフィス・インターベンショナル・スイートの市場は、インターベンションラジオロジー (IVR) 専門医や血管外科医、その他の専門家が好む患者中心型治療モデルによって牽引力を増しています。血管疾患、特に末梢動脈疾患 (PAD) の有病率の増加は、米国の成人約850万人に影響を及ぼしており、低侵襲処置と外来手術環境に対する需要を促進しています。便利な医療オプションへの嗜好が高まり、医療費が増加する中、OBLは患者にも医療提供者にも人気の選択肢となっています。専門的な治療チームによる患者満足度の向上が市場成長をさらに後押しし、オフィス・インターベンショナル・スイートは進化する医療の重要な構成要素となっています。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場魅力度指数 (2024年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析
• 規制分析
• 特許分析
• ケーススタディ

世界のオフィスベースラボの市場規模・CAGR：セットアップモデル別 (2025～2032年)

• 市場概要
• 単一用途
• 多用途
• ハイブリッド

世界のオフィスベースラボの市場規模・CAGR：サービスの種類別 (2025～2032年)

• 市場概要
• 末梢血管介入
• インターベンショナルラジオロジー (IVR)
• 血管内治療
• 心臓血管
• 静脈
• 非血管性

世界のオフィスベースラボの市場規模・CAGR：専門家別 (2025～2032年)

• 市場概要
• 血管外科医
• 心臓インターベンション専門医
• インターベンショナルラジオロジー専門医

世界のオフィスベースラボの市場規模・CAGR (2025～2032年)

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング (2024年)
• 主要企業が採用した戦略
• 市場の近年の動向
• 主要企業の市場シェア (2024年)
• 主要企業のプロファイル
  • 企業概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2022～2024年)

主要企業のプロファイル

• Koninklijke Philips N.V. (オランダ)
• GE Healthcare (米国)
• Siemens Healthineers (ドイツ)
• Medtronic (米国)
• Cardiovascular Systems, Inc. (米国)
• Envision Healthcare (米国)
• Surgery Care Associate, Inc. (米国)
• Surgery Partners (米国)
• Fresenius Medical Care (ドイツ)
• Terveystalo Healthcare (フィンランド)
• Healthway Medical (米国)
• Quorum Health (米国)
• HCA Healthcare (米国)
• Tenet Healthcare (米国)
• Mednax (米国)
• Ambulatory Surgical Centers of America (ASCOA) (米国)
• U.S. Renal Care, Inc. (米国)
• Arthrex, Inc. (米国)
• Medtronic (米国)
• Stryker Corporation (米国)

結論と推奨事項

Global Office-based Labs Market size was valued at USD 30.6 billion in 2023 and is poised to grow from USD 34.43 billion in 2024 to USD 88.33 billion by 2032, growing at a CAGR of 12.5% during the forecast period (2025-2032).

The global market for office-based labs (OBLs), or office interventional suites, is gaining traction due to a patient-centered care model favored by interventional radiologists, vascular surgeons, and other specialists. The increasing prevalence of vascular diseases, particularly Peripheral Arterial Disease (PAD) - affecting about 8.5 million adults in the U.S. - is driving demand for minimally invasive procedures and outpatient surgical settings. With a growing preference for convenient healthcare options and rising spending on healthcare, OBLs are becoming a popular choice for patients and healthcare providers alike. Enhanced patient satisfaction stemming from specialized care teams further propels market growth, positioning office interventional suites as a vital component of the evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Office-Based Labs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Office-Based Labs Market Segmental Analysis

Global Office-based Labs Market is segmented by Set-up Model, Service Type, Specialist and region. Based on Set-up Model, the market is segmented into Single Specialty, Multi-Specialty and Hybrid. Based on Service Type, the market is segmented into Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular, Venous and Non-vascular. Based on Specialist, the market is segmented into Vascular Surgeons, Interventional Cardiologists and Interventional Radiologists. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Office-Based Labs Market

The Global Office-Based Labs (OBLs) market is significantly driven by exceptionally high patient satisfaction levels, which exceed 97%. This impressive rate can be attributed to the superior quality of staff and the efficient services provided at these labs. OBLs boast highly trained specialists and technologists who are dedicated to patient care. Furthermore, their meticulous record-keeping enhances the quality of service, ensuring that patients receive tailored care effectively. As a result, the seamless operations within OBLs, combined with strong patient satisfaction, are poised to contribute to substantial growth in the office-based lab market in the coming years.

Restraints in the Global Office-Based Labs Market

The global office-based labs market faces significant restraints due to the necessity for highly skilled medical professionals. Many physicians struggle to balance the demands of managing a medical practice with the complexities of operating an office-based lab. Additionally, these facilities often lack the advanced equipment and resources available in hospitals, which can hinder their development and ability to provide comprehensive care. Furthermore, the increasing occurrence of complications arising from high-acuity cases presents an additional challenge, thereby impeding the overall growth and acceptance of office-based labs in the healthcare landscape. Addressing these issues is crucial for the market's advancement.

Market Trends of the Global Office-Based Labs Market

The Global Office-Based Labs market is witnessing a significant trend towards the adoption of advanced technologies that enhance the safety and efficacy of same-day interventions in freestanding facilities. A prime advancement is the development of Chronic Total Occlusion (CTO) crossing techniques, which enable predictable and efficient treatment of lower extremity artery long CTOs. The utilization of various specialized devices, including specialty wires, crossing catheters, and atherectomy tools catering to different plaque compositions and lesion characteristics, underscores the market's evolution. Furthermore, the advent of reliable re-entry devices has revolutionized intervention success, fostering increased competitiveness and growth within the office-based lab sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Office-based Labs Market Size by Set-up Model & CAGR (2025-2032)

• Market Overview
• Single Specialty
• Multi-Specialty
• Hybrid

Global Office-based Labs Market Size by Service Type & CAGR (2025-2032)

• Market Overview
• Peripheral Vascular Intervention
• Interventional Radiology
• Endovascular Therapy
• Cardiovascular
• Venous
• Non-vascular

Global Office-based Labs Market Size by Specialist & CAGR (2025-2032)

• Market Overview
• Vascular Surgeons
• Interventional Cardiologists
• Interventional Radiologists

Global Office-based Labs Market Size & CAGR (2025-2032)

• North America (Set-up Model, Service Type, Specialist)
  • US
  • Canada
• Europe (Set-up Model, Service Type, Specialist)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Set-up Model, Service Type, Specialist)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Set-up Model, Service Type, Specialist)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Set-up Model, Service Type, Specialist)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envision Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgery Care Associate, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgery Partners (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terveystalo Healthcare (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healthway Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quorum Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HCA Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tenet Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mednax (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambulatory Surgical Centers of America (ASCOA) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• U.S. Renal Care, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations